News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
697,135 Results
Type
Article (39901)
Company Profile (250)
Press Release (656984)
Section
Business (204996)
Career Advice (2016)
Deals (35515)
Drug Delivery (96)
Drug Development (81257)
Employer Resources (169)
FDA (16254)
Job Trends (14883)
News (346721)
Policy (33067)
Tag
Academia (2562)
Alliances (49583)
Alzheimer's disease (1323)
Approvals (16240)
Artificial intelligence (209)
Bankruptcy (357)
Best Places to Work (11666)
Biotechnology (177)
Breast cancer (231)
Cancer (1781)
Cardiovascular disease (132)
Career advice (1680)
CAR-T (128)
Cell therapy (369)
Clinical research (65577)
Collaboration (690)
Compensation (381)
COVID-19 (2587)
C-suite (172)
Data (1694)
Diabetes (224)
Diagnostics (6317)
Earnings (86034)
Employer resources (145)
Events (111712)
Executive appointments (584)
FDA (17200)
Funding (622)
Gene therapy (255)
GLP-1 (662)
Government (4635)
Healthcare (18938)
Infectious disease (2704)
Interviews (313)
IPO (16512)
Job creations (3652)
Job search strategy (1431)
Layoffs (442)
Legal (7956)
Lung cancer (260)
Manufacturing (242)
Medical device (13340)
Medtech (13345)
Mergers & acquisitions (19396)
Metabolic disorders (580)
Neuroscience (1744)
NextGen: Class of 2025 (6534)
Non-profit (4520)
Northern California (2191)
Obesity (320)
Opinion (197)
Patents (174)
People (57150)
Phase I (20395)
Phase II (28870)
Phase III (21542)
Pipeline (785)
Postmarket research (2575)
Preclinical (8611)
Radiopharmaceuticals (243)
Rare diseases (332)
Real estate (5928)
Regulatory (22245)
Research institute (2331)
Resumes & cover letters (349)
Southern California (1875)
Startups (3585)
United States (19195)
Vaccines (625)
Weight loss (220)
Date
Today (137)
Last 7 days (787)
Last 30 days (2735)
Last 365 days (34461)
2025 (5393)
2024 (35306)
2023 (40171)
2022 (51326)
2021 (55914)
2020 (54363)
2019 (46937)
2018 (35321)
2017 (32267)
2016 (31713)
2015 (37758)
2014 (31487)
2013 (26504)
2012 (28711)
2011 (29398)
2010 (27478)
Location
Africa (732)
Arizona (212)
Asia (37747)
Australia (6191)
California (4985)
Canada (1766)
China (411)
Colorado (227)
Connecticut (235)
Europe (81150)
Florida (733)
Georgia (171)
Illinois (463)
Indiana (272)
Japan (127)
Maryland (760)
Massachusetts (3777)
Michigan (200)
Minnesota (345)
New Jersey (1408)
New York (1420)
North Carolina (857)
Northern California (2191)
Ohio (174)
Pennsylvania (1134)
South America (1104)
Southern California (1875)
Texas (725)
Utah (153)
Washington State (476)
697,135 Results for "sobi canada inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada
February 26, 2025
·
4 min read
Press Releases
Apellis and Sobi Announce EMA Validation of Indication Extension Application for Aspaveli® (pegcetacoplan) for C3G and Primary IC-MPGN
February 20, 2025
·
6 min read
Press Releases
Palisade Bio, Inc. Announces Receipt of Cash Proceeds from Canada’s SR&ED Tax Incentive Program for Reimbursement of Development Costs of PALI-2108 for Treatment of Ulcerative Colitis (UC)
February 20, 2025
·
4 min read
Policy
European Commission grants Sobi® Marketing Authorisation for ALTUVOCT™ for treatment of haemophilia A
Sobi® announced the European Commission has granted Marketing Authorisation for ALTUVOCT™, for the treatment and prevention of bleeds and perioperative prophylaxis in haemophilia A. ALTUVOCT is a high-sustained factor VIII replacement therapy for all ages and any disease severity.
June 19, 2024
·
7 min read
Press Releases
Enable Injections Announces Agreement with Sobi® to Develop and Distribute Aspaveli® in Combination with enFuse® in Sobi Territories
September 13, 2024
·
3 min read
Press Releases
Sobi Announces FDA Acceptance of New Drug Application for Avatrombopag (DOPTELET®) for the Treatment of Pediatric Immune Thrombocytopenia
December 12, 2024
·
5 min read
Press Releases
Boehringer Canada Announces Availability of SPEVIGO® for expanded indication in Canada
February 6, 2025
·
7 min read
Genetown
Sobi to present new myelofibrosis data at the ASCO 2024 Annual Meeting
Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB, announced the presentation of three abstracts that highlights data from its myelofibrosis treatment option at the American Society of Clinical Oncology Annual Meeting taking place in Chicago from May 31 – June 4, 2024.
May 24, 2024
·
8 min read
Press Releases
Sobi to present new data across its immunology portfolio at the ACR Convergence 2024
November 8, 2024
·
6 min read
Policy
Sobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Activation Syndrome
Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB, announced that the US Food and Drug Administration has granted Fast Track designation to emapalumab-lzsg being investigated as a potential therapeutic option in patients with Macrophage Activation Syndrome.
May 24, 2024
·
5 min read
1 of 69,714
Next
